William John Sibold insider trades

Open-market stock purchases and sales by William John Sibold, President and CEO at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since May 3, 2011.

Recent trades

DateStockTradeValue
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$837K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$32K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$56.6K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$117K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$86K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$371K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$199K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$652K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$415K
Sep 11, 2026MDGL Madrigal Pharmaceuticals, IncSold$65.6K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$69.2K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$184K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$277K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$196K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$273K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$212K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$345K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$558K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$344K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$280K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$116K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$273K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$196K
Sep 9, 2026MDGL Madrigal Pharmaceuticals, IncSold$86.8K
Jul 20, 2026MDGL Madrigal Pharmaceuticals, IncSold$76K

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: 42 sales, last Sep 11, 2026
  • AVNR Avanir Pharmaceuticals, Inc: other filings, last May 3, 2011

Get free alerts when William John Sibold files a new trade →